Hippo (HIPO) Financials

Hippo logo
$37.99 +0.07 (+0.18%)
Closing price 03:59 PM Eastern
Extended Trading
$37.96 -0.03 (-0.09%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Hippo

Annual Income Statements for Hippo

This table shows Hippo's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-142 -371 -333 -273 -41 58
Consolidated Net Income / (Loss)
-141 -368 -327 -263 -29 63
Net Income / (Loss) Continuing Operations
-336 -169 -327 -263 -29 63
Total Pre-Tax Income
-143 -367 -325 -263 -27 63
Total Operating Income
-117 -215 -328 -263 -82 -32
Total Gross Profit
7.00 -35 -42 -51 74 107
Total Revenue
52 91 120 210 372 469
Operating Revenue
52 91 120 210 372 469
Total Cost of Revenue
45 126 161 261 298 361
Operating Cost of Revenue
45 126 161 261 298 361
Total Operating Expenses
124 180 286 211 156 139
Selling, General & Admin Expense
37 49 72 80 71 67
Marketing Expense
69 95 102 80 51 34
Research & Development Expense
18 36 58 47 31 33
Other Operating Expenses / (Income)
- - - -0.80 -0.10 1.00
Restructuring Charge
- 0.00 55 5.50 3.60 5.00
Total Other Income / (Expense), net
-221 47 0.00 0.00 54 95
Other Income / (Expense), net
-195 - 0.00 0.00 54 95
Income Tax Expense
-1.80 0.70 1.30 0.50 1.20 0.70
Net Income / (Loss) Attributable to Noncontrolling Interest
0.10 3.50 6.90 10 12 4.90
Basic Earnings per Share
($1.63) ($34.11) ($14.66) ($11.58) ($1.64) $2.28
Weighted Average Basic Shares Outstanding
86.90M 10.89M 22.75M 23.58M 24.70M 25.25M
Diluted Earnings per Share
($1.63) ($34.11) ($14.66) ($11.58) ($1.64) $2.22
Weighted Average Diluted Shares Outstanding
86.90M 10.89M 22.75M 23.58M 24.70M 26.01M
Weighted Average Basic & Diluted Shares Outstanding
- 566.27M 23.31M 24.31M 25.08M 25.97M

Quarterly Income Statements for Hippo

This table shows Hippo's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-36 -41 -8.50 44 -48 1.30 98 6.00 7.10 10 8.80
Consolidated Net Income / (Loss)
-33 -37 -5.20 47 -45 3.90 98 6.00 7.10 10 8.80
Net Income / (Loss) Continuing Operations
-33 -37 -5.20 47 -45 3.90 98 6.00 7.10 10 8.80
Total Pre-Tax Income
-33 -37 -5.20 47 -46 4.00 98 6.80 7.20 11 8.90
Total Operating Income
-33 -37 -13 1.00 -46 4.00 3.10 6.80 7.20 11 8.90
Total Gross Profit
12 4.70 21 37 -12 40 40 40 39 46 44
Total Revenue
85 90 96 102 110 117 121 120 122 145 156
Operating Revenue
85 90 96 102 110 117 121 120 122 145 156
Total Cost of Revenue
73 85 74 65 123 77 80 81 82 99 112
Operating Cost of Revenue
73 85 74 65 123 77 80 81 82 99 112
Total Operating Expenses
45 41 35 36 33 36 37 33 32 35 35
Selling, General & Admin Expense
18 20 15 17 17 17 17 17 16 18 17
Marketing Expense
14 13 13 11 8.90 9.20 8.00 7.40 6.30 6.30 5.90
Research & Development Expense
8.30 7.80 7.00 7.60 8.10 8.10 8.00 8.30 9.40 10 11
Other Operating Expenses / (Income)
0.00 0.10 -0.10 -0.10 -0.20 0.10 0.80 0.30 0.00 0.60 1.20
Restructuring Charge
3.60 0.00 0.00 - - 1.20 3.80 - - 0.00 0.00
Total Other Income / (Expense), net
0.00 0.00 8.20 46 0.00 0.00 95 - 0.00 0.00 0.00
Other Income / (Expense), net
- - 8.20 - - - 95 - - - 0.00
Income Tax Expense
0.20 0.70 0.00 0.30 -0.20 0.10 0.00 0.80 0.10 0.90 0.10
Net Income / (Loss) Attributable to Noncontrolling Interest
2.60 3.30 3.30 2.70 2.30 2.60 0.00 - 0.00 0.00 0.00
Basic Earnings per Share
($1.47) ($1.64) ($0.34) $1.81 ($1.91) $0.05 $3.90 $0.24 $0.27 $0.38 $0.33
Weighted Average Basic Shares Outstanding
24.23M 24.63M 25.07M 24.70M 24.98M 25.34M 25.18M 25.25M 25.84M 26.20M 26.50M
Diluted Earnings per Share
($1.47) ($1.64) ($0.34) $1.81 ($1.91) $0.05 $3.77 $0.31 $0.27 $0.38 $0.33
Weighted Average Diluted Shares Outstanding
24.23M 24.63M 25.07M 24.70M 24.98M 26.02M 26.03M 26.01M 26.35M 26.55M 27.03M
Weighted Average Basic & Diluted Shares Outstanding
24.43M 24.36M - 25.08M 25.16M 25.03M 25.34M 25.97M 26.04M 26.39M 26.62M

Annual Cash Flow Statements for Hippo

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
450 326 -574 -49 38 17
Net Cash From Operating Activities
-65 -125 -162 -92 48 9.20
Net Cash From Continuing Operating Activities
-65 -125 -162 -92 48 9.20
Net Income / (Loss) Continuing Operations
-141 -368 -327 -263 -29 63
Consolidated Net Income / (Loss)
-141 -368 -327 -263 -29 63
Depreciation Expense
6.70 11 15 20 23 20
Non-Cash Adjustments To Reconcile Net Income
78 241 180 188 89 20
Changes in Operating Assets and Liabilities, net
-8.20 -29 -30 -37 -36 -94
Net Cash From Investing Activities
-2.30 -30 -406 58 30 -11
Net Cash From Continuing Investing Activities
-2.30 -30 -406 58 30 -11
Purchase of Property, Plant & Equipment
-9.40 -14 -20 -47 -12 -13
Purchase of Investments
-17 -26 -793 -410 -368 -426
Divestitures
- - 0.00 0.00 67 66
Sale and/or Maturity of Investments
108 17 409 517 337 362
Other Investing Activities, net
0.00 -2.90 -2.00 -3.20 6.00 0.00
Net Cash From Financing Activities
518 481 -6.80 -15 -40 19
Net Cash From Continuing Financing Activities
518 481 -6.80 -15 -40 19
Repurchase of Common Equity
- - 0.00 -1.80 -16 -15
Payment of Dividends
- - -5.30 -9.60 -20 -8.10
Issuance of Debt
- - - 0.00 0.00 48
Issuance of Common Equity
- - 4.10 2.80 6.70 3.80
Other Financing Activities, net
-1.50 482 -5.60 -6.00 -11 -9.80

Quarterly Cash Flow Statements for Hippo

This table details how cash moves in and out of Hippo's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
51 -43 -36 56 -17 21 30 -16 46 -76 -17
Net Cash From Operating Activities
18 -11 47 -6.40 -36 25 17 3.20 8.50 43 73
Net Cash From Investing Activities
59 -28 -28 28 -11 -22 47 -26 43 -77 -17
Net Cash From Continuing Investing Activities
59 -28 -28 28 -11 -22 47 -26 43 -77 -17
Purchase of Property, Plant & Equipment
-3.40 -3.80 -3.40 -1.40 -2.90 -3.40 -3.50 -3.50 -3.20 -3.30 -3.60
Purchase of Investments
-55 -84 -105 -124 -66 -132 -102 -126 -95 -242 -43
Sale and/or Maturity of Investments
117 60 61 100 58 114 87 104 115 168 30
Net Cash From Financing Activities
-8.00 -4.40 -8.20 -20 -6.00 43 -18 0.40 3.70 0.90 -0.60
Net Cash From Continuing Financing Activities
-8.00 -4.40 -8.20 -20 -6.00 43 -18 0.40 3.70 0.90 -0.60
Repayment of Debt
- - - - -1.00 - - - 2.70 -0.20 -1.00
Issuance of Common Equity
1.00 1.20 0.80 3.70 1.00 1.30 0.50 1.00 1.00 1.10 0.40

Annual Balance Sheets for Hippo

This table presents Hippo's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
979 1,643 1,569 1,525 1,543 1,906
Total Current Assets
489 841 627 287 365 468
Cash & Equivalents
452 776 195 142 198 218
Accounts Receivable
37 57 107 145 167 250
Plant, Property, & Equipment, net
0.00 0.00 0.00 162 206 293
Plant, Property & Equipment, gross
- - - 162 206 293
Total Noncurrent Assets
490 802 942 1,076 973 1,144
Long-Term Investments
56 55 121 187 168 153
Intangible Assets
49 58 66 76 65 57
Other Noncurrent Operating Assets
338 635 756 813 740 934
Total Liabilities & Shareholders' Equity
979 1,643 1,569 1,525 1,543 1,906
Total Liabilities
834 781 975 1,140 1,178 1,469
Total Current Liabilities
234 516 629 696 686 806
Accrued Expenses
43 95 128 114 87 81
Other Current Liabilities
191 420 501 583 599 725
Total Noncurrent Liabilities
600 265 346 444 492 664
Long-Term Debt
273 - - - 0.00 48
Other Noncurrent Operating Liabilities
327 265 346 444 492 616
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-200 862 594 385 365 436
Total Preferred & Common Equity
-200 860 590 378 362 436
Total Common Equity
-200 860 590 378 362 436
Common Stock
57 1,488 1,558 1,615 1,640 1,652
Retained Earnings
-257 -628 -961 -1,234 -1,275 -1,217
Accumulated Other Comprehensive Income / (Loss)
0.10 -0.70 -7.00 -2.90 -2.70 1.80

Quarterly Balance Sheets for Hippo

This table presents Hippo's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
1,605 1,681 1,647 1,496 1,545 1,540 1,706 1,874 2,062 2,319 2,752
Total Current Assets
613 577 562 502 743 314 426 484 558 595 732
Cash & Equivalents
189 200 228 223 191 141 199 248 275 245 312
Accounts Receivable
134 148 145 154 158 173 227 237 282 351 421
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00 212 237 246 299 431 436
Plant, Property & Equipment, gross
- - - - - 212 237 246 299 431 436
Total Noncurrent Assets
992 1,104 1,085 994 802 1,015 1,043 1,144 1,206 1,292 1,584
Long-Term Investments
141 136 142 163 - 175 168 175 125 67 63
Intangible Assets
67 69 71 75 74 64 62 57 56 55 54
Other Noncurrent Operating Assets
784 899 873 757 728 776 814 912 1,025 1,170 1,467
Total Liabilities & Shareholders' Equity
1,605 1,681 1,647 1,496 1,545 1,540 1,706 1,874 2,062 2,319 2,752
Total Liabilities
1,062 1,234 1,236 1,142 1,215 1,215 1,372 1,452 1,613 1,853 2,283
Total Current Liabilities
687 798 776 705 710 730 780 802 911 1,025 1,317
Accrued Expenses
133 128 125 105 98 91 77 85 72 80 84
Other Current Liabilities
555 670 651 600 612 639 692 717 839 945 1,233
Total Noncurrent Liabilities
374 436 460 436 505 485 593 650 703 828 966
Long-Term Debt
- - - - - - 48 48 48 48 48
Other Noncurrent Operating Liabilities
374 436 460 436 505 485 545 602 655 780 919
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
543 447 411 355 330 326 334 422 449 466 469
Total Preferred & Common Equity
538 446 407 351 326 323 333 422 449 466 469
Total Common Equity
538 446 407 351 326 323 333 422 449 466 469
Common Stock
1,575 1,591 1,606 1,625 1,645 1,646 1,654 1,643 1,659 1,668 1,675
Retained Earnings
-1,031 -1,139 -1,192 -1,270 -1,319 -1,323 -1,321 -1,223 -1,210 -1,200 -1,191
Accumulated Other Comprehensive Income / (Loss)
-5.30 -6.40 -7.10 -3.40 0.50 -0.60 0.10 1.40 -0.60 -2.00 -15

Annual Metrics And Ratios for Hippo

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - - 25,335,179.00
DEI Adjusted Shares Outstanding
- - - - - 25,335,179.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - 2.28
Growth Metrics
- - - - - -
Profitability Metrics
- - - - - -
Net Operating Profit after Tax (NOPAT)
-82 -151 -229 -184 -57 -31
Return On Investment Capital (ROIC_SIMPLE)
- - -38.65% -47.91% -15.70% -6.48%
Earnings before Interest and Taxes (EBIT)
-312 -215 -328 -263 -28 63
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-305 -184 -313 -244 -4.30 84
Valuation Ratios
- - - - - -
Leverage & Solvency
- - - - - -
Liquidity Ratios
- - - - - -
Cash Flow Metrics
- - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -263 -160 -287 -1.83 181
Efficiency Ratios
- - - - - -
Capital & Investment Metrics
- - - - - -
Invested Capital
-90 22 -47 56 0.00 -212
Increase / (Decrease) in Invested Capital
0.00 112 -69 102 -56 -212
Book Value per Share
($2.30) $1.53 $25.58 $15.82 $14.86 $17.21
Tangible Book Value per Share
($3.41) $1.33 $22.73 $12.65 $12.19 $14.97
Total Capital
418 862 594 385 365 484
Total Debt
273 0.00 0.00 0.00 0.00 48
Total Long-Term Debt
273 0.00 0.00 0.00 0.00 48
Net Debt
-235 -840 -640 -329 -365 -648
Capital Expenditures (CapEx)
9.40 14 20 47 12 13
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-197 -459 -522 -551 -519 -251
Debt-free Net Working Capital (DFNWC)
255 326 -2.60 -409 -321 445
Net Working Capital (NWC)
255 326 -2.60 -409 -321 445
Net Nonoperating Expense (NNE)
59 217 97 79 -29 -94
Net Nonoperating Obligations (NNO)
-235 -840 -640 -329 -365 -648
Total Depreciation and Amortization (D&A)
6.70 31 15 20 23 20
Earnings Adjustments
- - - - - -
Adjusted Basic Earnings per Share
$0.00 ($34.00) ($14.66) ($11.58) ($1.64) $2.28
Adjusted Weighted Average Basic Shares Outstanding
0.00 10.89M 22.75M 23.58M 24.70M 25.25M
Adjusted Diluted Earnings per Share
$0.00 ($34.00) ($14.66) ($11.58) ($1.64) $2.22
Adjusted Weighted Average Diluted Shares Outstanding
0.00 10.89M 22.75M 23.58M 24.70M 26.01M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 22.65M 23.31M 24.31M 25.08M 25.97M
Normalized Net Operating Profit after Tax (NOPAT)
-82 -151 -191 -180 -55 -26
Debt Service Ratios
- - - - - -
Payout Ratios
- - - - - -

Quarterly Metrics And Ratios for Hippo

This table displays calculated financial ratios and metrics derived from Hippo's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 9/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - 24,359,710.00 - - - 25,335,179.00 25,970,978.00 26,035,917.00 26,389,381.00
DEI Adjusted Shares Outstanding
- - - 24,359,710.00 - - - 25,335,179.00 25,970,978.00 26,035,917.00 26,389,381.00
DEI Earnings Per Adjusted Shares Outstanding
- - - 1.81 - - - 0.24 0.27 0.39 0.33
Growth Metrics
- - - - - - - - - - -
Revenue Growth
113.82% 100.21% 65.51% - 29.61% 30.92% 26.28% - 10.15% 23.36% 29.35%
EBITDA Growth
56.80% 100.70% 88.62% - -38.60% 110.96% 1,986.54% - 115.79% 175.00% -90.93%
EBIT Growth
51.26% 95.05% 89.72% - -38.60% 110.96% 1,986.54% - 115.79% 175.00% -90.93%
NOPAT Growth
51.26% 95.05% 73.52% - -38.60% 115.26% 133.05% - 122.24% 158.97% 183.87%
Net Income Growth
51.40% 95.06% 89.66% - -37.16% 110.48% 1,986.54% - 115.64% 158.97% -91.03%
EPS Growth
51.16% 92.62% 84.82% - -29.93% 103.05% 1,208.82% - 114.14% 660.00% -91.25%
Operating Cash Flow Growth
149.58% -13.98% 4,154.55% - -301.13% 333.02% -63.89% - 123.88% 74.49% 329.59%
Free Cash Flow Firm Growth
-16.35% 110.14% -313.25% - -454.45% -347.43% 71.95% - 59.71% 40.04% -97.04%
Invested Capital Growth
-101.81% -116.92% 0.00% - 106.03% 110.11% 0.00% - 921.28% 682.95% 202.77%
Revenue Q/Q Growth
31.94% 12.22% 6.58% - 0.00% 6.35% 2.81% - 0.91% 19.09% 7.81%
EBITDA Q/Q Growth
21.55% 102.56% 85.75% - 0.00% 108.77% 2,352.50% - 5.88% 52.78% -19.09%
EBIT Q/Q Growth
18.16% 84.19% 85.75% - 0.00% 108.77% 2,352.50% - 5.88% 52.78% -19.09%
NOPAT Q/Q Growth
18.16% 84.19% 63.29% - 0.00% 112.22% -20.51% - 18.33% 42.25% -12.87%
Net Income Q/Q Growth
15.99% 84.29% 86.02% - 0.00% 108.59% 2,415.38% - 18.33% 42.25% -12.87%
EPS Q/Q Growth
18.33% 76.87% 79.27% - 0.00% 102.62% 7,440.00% - -12.90% 40.74% -13.16%
Operating Cash Flow Q/Q Growth
136.49% -159.89% 541.51% - 0.00% 169.38% -31.58% - 165.63% 407.06% 68.45%
Free Cash Flow Firm Q/Q Growth
-33.85% 140.45% -239.78% - 0.00% -40.38% 84.15% - 25.84% -108.93% 47.92%
Invested Capital Q/Q Growth
2.01% -63.53% 100.00% - 0.00% 174.47% 82.17% - -15.19% 110.42% -29.55%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
13.75% 22.30% 22.30% - -11.15% 34.10% 33.33% - 32.18% 31.93% 28.21%
EBITDA Margin
-32.08% 0.73% -5.45% - -41.34% 3.41% 81.34% - 5.93% 7.60% 5.71%
Operating Margin
-38.66% -5.45% -14.03% - -41.34% 3.41% 2.57% - 5.93% 7.60% 5.71%
EBIT Margin
-38.66% -5.45% -5.45% - -41.34% 3.41% 81.34% - 5.93% 7.60% 5.71%
Profit (Net Income) Margin
-38.90% -5.45% -5.45% - -41.16% 3.32% 81.34% - 5.84% 6.98% 5.64%
Tax Burden Percent
100.61% 100.00% 100.00% - 99.56% 97.50% 100.00% - 98.61% 91.82% 98.88%
Interest Burden Percent
100.00% 100.00% 100.00% - 100.00% 100.00% 100.00% - 100.00% 100.00% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% - 0.00% 2.50% 0.00% - 1.39% 8.18% 1.12%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% - 0.00% 0.00% 49.23% - 53.20% 31.08% 32.34%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% - 0.00% 0.00% -1.50% - 53.20% 31.08% 32.34%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% - 0.00% 0.00% 1.33% - -45.96% -22.23% -25.46%
Return on Equity (ROE)
-50.79% -32.94% 0.00% - -12.02% 0.06% 50.57% - 7.24% 8.85% 6.87%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% - -2,464.04% -1,193.60% -359.69% - -124.63% -130.39% -66.88%
Operating Return on Assets (OROA)
-6.36% -1.02% 0.00% - -10.82% 0.89% 19.54% - 1.58% 1.92% 1.34%
Return on Assets (ROA)
-6.40% -1.02% 0.00% - -10.77% 0.87% 19.54% - 1.56% 1.76% 1.32%
Return on Common Equity (ROCE)
-50.32% -32.73% 0.00% - -11.91% 0.06% 50.57% - 7.21% 8.84% 6.87%
Return on Equity Simple (ROE_SIMPLE)
-64.92% -39.22% 0.00% - -12.67% 0.00% 0.00% - 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-23 -3.64 -9.38 0.99 -32 3.90 3.10 6.00 7.10 10 8.80
NOPAT Margin
-27.06% -3.81% -9.82% - -28.94% 3.32% 2.57% - 5.84% 6.98% 5.64%
Net Nonoperating Expense Percent (NNEP)
-1.78% -0.27% 0.00% - -3.26% 0.00% 50.73% - 0.00% 0.00% 0.00%
Return On Investment Capital (ROIC_SIMPLE)
- - - 0.27% -9.80% 1.02% 0.66% 1.24% 1.43% 1.97% 1.70%
Cost of Revenue to Revenue
86.25% 77.70% 77.70% - 111.15% 65.90% 66.67% - 67.82% 68.07% 71.79%
SG&A Expenses to Revenue
21.50% 16.02% 16.02% - 14.96% 14.83% 13.68% - 13.33% 12.58% 10.90%
R&D to Revenue
9.75% 7.33% 7.33% - 7.34% 6.91% 6.63% - 7.74% 6.98% 7.05%
Operating Expenses to Revenue
52.41% 27.75% 36.34% - 30.19% 30.69% 30.76% - 26.26% 24.33% 22.50%
Earnings before Interest and Taxes (EBIT)
-33 -5.20 -5.20 1.00 -46 4.00 98 6.80 7.20 11 8.90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-27 0.70 -5.20 1.00 -46 4.00 98 6.80 7.20 11 8.90
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.26 1.29 0.00 - 1.99 2.11 2.15 - 1.51 1.58 1.73
Price to Tangible Book Value (P/TBV)
1.61 1.67 0.00 - 2.47 2.59 2.48 - 1.72 1.79 1.96
Price to Revenue (P/Rev)
1.74 1.39 1.26 - 1.61 1.65 2.01 - 1.41 1.45 1.50
Price to Earnings (P/E)
0.00 0.00 0.00 - 0.00 0.00 9.44 - 6.02 6.07 25.38
Dividend Yield
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% - 0.00% 0.00% 10.60% - 16.62% 16.49% 3.94%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 - 34.86 14.94 11.29 - 3.38 2.34 3.41
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 - 0.82 0.91 1.18 - 0.68 0.93 0.89
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 15.36 16.80 14.32
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 15.36 16.80 14.32
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 15.49 17.05 15.17
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 - 0.00 13.07 0.00 - 6.08 6.59 3.81
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 - 0.00 0.14 0.11 - 0.11 0.10 0.10
Long-Term Debt to Equity
0.00 0.00 0.00 - 0.00 0.14 0.11 - 0.11 0.10 0.10
Financial Leverage
-1.26 -1.48 0.00 - -1.22 -1.35 -0.89 - -0.86 -0.72 -0.79
Leverage Ratio
3.45 4.15 0.00 - 4.46 4.90 4.45 - 4.65 5.03 5.19
Compound Leverage Factor
3.45 4.15 0.00 - 4.46 4.90 4.45 - 4.65 5.03 5.19
Debt to Total Capital
0.00% 0.00% 0.00% - 0.00% 12.54% 10.20% - 9.65% 9.33% 9.27%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% - 0.00% 12.54% 10.20% - 9.65% 9.33% 9.27%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% - 0.00% 0.00% 0.00% - 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
1.01% 1.12% 0.00% - 0.89% 0.42% 0.00% - 0.00% 0.00% 0.00%
Common Equity to Total Capital
98.99% 98.88% 0.00% - 99.11% 87.04% 89.80% - 90.35% 90.67% 90.73%
Debt to EBITDA
0.00 0.00 0.00 - 0.00 -0.89 -1.27 - 2.27 1.70 1.41
Net Debt to EBITDA
0.00 0.00 0.00 - 0.00 5.89 9.96 - -16.72 -9.38 -9.64
Long-Term Debt to EBITDA
0.00 0.00 0.00 - 0.00 -0.89 -1.27 - 2.27 1.70 1.41
Debt to NOPAT
0.00 0.00 0.00 - 0.00 -1.77 -1.28 - 2.29 1.73 1.50
Net Debt to NOPAT
0.00 0.00 0.00 - 0.00 11.79 9.98 - -16.86 -9.52 -10.21
Long-Term Debt to NOPAT
0.00 0.00 0.00 - 0.00 -1.77 -1.28 - 2.29 1.73 1.50
Altman Z-Score
-1.02 -0.78 0.00 - -1.05 -0.77 -0.33 - -0.53 -0.47 -0.44
Noncontrolling Interest Sharing Ratio
0.92% 0.66% 0.00% - 0.96% 0.80% 0.00% - 0.37% 0.20% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.71 1.05 0.00 - 0.43 0.55 0.60 - 0.61 0.58 0.56
Quick Ratio
0.71 0.99 0.00 - 0.43 0.55 0.60 - 0.61 0.58 0.56
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
56 134 -156 56 -197 -277 -44 218 -80 -166 -87
Operating Cash Flow to CapEx
520.59% -278.95% 1,376.47% - -1,227.59% 726.47% 482.86% - 265.63% 1,306.06% 2,016.67%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.16 0.19 0.00 - 0.26 0.26 0.24 - 0.27 0.25 0.23
Accounts Receivable Turnover
1.77 1.98 0.00 - 2.43 2.21 1.90 - 2.11 1.76 1.65
Inventory Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 - 0.00 0.00 1.83 - 1.88 1.52 1.59
Accounts Payable Turnover
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Sales Outstanding (DSO)
205.69 184.43 0.00 - 150.02 165.28 191.95 - 173.03 207.98 221.08
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Cash Conversion Cycle (CCC)
205.69 184.43 0.00 - 150.02 165.28 191.95 - 173.03 207.98 221.08
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-156 -255 0.00 0.00 9.40 26 47 -212 96 202 142
Invested Capital Turnover
-2.19 -1.62 0.00 - -5.42 -3.71 19.15 - 9.10 4.45 5.73
Increase / (Decrease) in Invested Capital
-79 -138 147 -56 165 281 47 -212 87 176 95
Enterprise Value (EV)
-63 -161 0.00 - 328 385 531 - 324 472 485
Market Capitalization
444 421 421 - 641 703 905 - 677 736 812
Book Value per Share
$14.45 $13.10 $0.00 $14.86 $12.87 $13.22 $16.84 $17.21 $17.28 $17.88 $17.77
Tangible Book Value per Share
$11.36 $10.13 $0.00 $12.19 $10.34 $10.77 $14.55 $14.97 $15.12 $15.77 $15.73
Total Capital
355 330 0.00 365 326 382 469 484 497 514 517
Total Debt
0.00 0.00 0.00 0.00 0.00 48 48 48 48 48 48
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 48 48 48 48 48 48
Net Debt
-511 -585 0.00 -365 -316 -319 -375 -648 -353 -264 -327
Capital Expenditures (CapEx)
3.40 3.80 3.40 1.40 2.90 3.40 3.50 3.50 3.20 3.30 3.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-551 -553 0.00 -519 -557 -553 -565 -251 -629 -675 -896
Debt-free Net Working Capital (DFNWC)
-203 33 0.00 -321 -416 -354 -317 445 -353 -430 -584
Net Working Capital (NWC)
-203 33 0.00 -321 -416 -354 -317 445 -353 -430 -584
Net Nonoperating Expense (NNE)
10 1.56 -4.18 -46 13 0.00 -95 0.00 0.00 0.00 0.00
Net Nonoperating Obligations (NNO)
-511 -585 0.00 -365 -316 -308 -375 -648 -353 -264 -327
Total Depreciation and Amortization (D&A)
5.60 5.90 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
-216.24% -182.50% 0.00% - -140.25% -130.00% -125.55% - -131.01% -132.99% -165.17%
Debt-free Net Working Capital to Revenue
-79.73% 10.77% 0.00% - -104.78% -83.20% -70.52% - -73.61% -84.78% -107.70%
Net Working Capital to Revenue
-79.73% 10.77% 0.00% - -104.78% -83.20% -70.52% - -73.61% -84.78% -107.70%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($1.47) ($0.34) $0.00 $1.81 ($1.91) $0.05 $3.90 $0.24 $0.27 $0.38 $0.33
Adjusted Weighted Average Basic Shares Outstanding
24.23M 25.07M 0.00 24.70M 24.98M 25.34M 25.18M 25.25M 25.84M 26.20M 26.50M
Adjusted Diluted Earnings per Share
($1.47) ($0.34) $0.00 $1.81 ($1.91) $0.05 $3.77 $0.31 $0.27 $0.38 $0.33
Adjusted Weighted Average Diluted Shares Outstanding
24.23M 25.07M 0.00 24.70M 24.98M 26.02M 26.03M 26.01M 26.35M 26.55M 27.03M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
24.43M 24.36M 0.00 25.08M 25.16M 25.03M 25.34M 25.97M 26.04M 26.39M 26.62M
Normalized Net Operating Profit after Tax (NOPAT)
-21 -9.38 -9.38 0.99 -32 5.07 4.83 6.00 7.10 10 8.80
Normalized NOPAT Margin
-24.10% -9.82% -9.82% - -28.94% 4.32% 4.01% - 5.84% 6.98% 5.64%
Pre Tax Income Margin
-38.66% -5.45% -5.45% - -41.34% 3.41% 81.34% - 5.93% 7.60% 5.71%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
-7.28% -10.55% -17.15% - -39.85% 8,850.00% 10.92% - 4.87% 1.40% 5.31%
Augmented Payout Ratio
-7.98% -10.55% -17.15% - -39.85% 8,850.00% 40.00% - 4.87% 1.40% 5.31%

Financials Breakdown Chart

Key Financial Trends

Hippo Holdings’ latest statements show a significant improvement in operating performance compared with 2022 and early 2024. Revenue increased from $28.7 million in Q2 2022 to $144.7 million in Q2 2026, while gross profit improved from a $17.9 million loss to $46.2 million. The company also moved from a $72.0 million operating loss in Q2 2022 to $11.0 million of operating income in Q2 2026.

Profitability has strengthened over the most recent quarters. Net income attributable to common shareholders rose from $1.3 million in Q2 2025 to $10.1 million in Q2 2026, while diluted earnings per share increased from $0.05 to $0.38. Hippo also reported positive net income in Q1 2026 and Q4 2025. However, the exceptionally large $98.1 million profit in Q3 2025 was primarily driven by $95.0 million of other income, making that quarter less representative of recurring operating performance.

Cash generation also improved in Q2 2026. Operating cash flow reached $43.1 million, up from $8.5 million in Q1 2026 and $3.2 million in Q4 2025. This was the strongest operating cash flow in the supplied recent data. Nevertheless, Hippo invested heavily in securities during the quarter, purchasing $241.9 million of investments while selling or allowing $168.0 million to mature. As a result, total cash and equivalents declined by $30.9 million during Q2 to $244.5 million.

The balance sheet has expanded substantially. Total assets grew from $1.50 billion in Q1 2024 to $2.32 billion in Q2 2026, and shareholders’ equity increased from $354.8 million to $465.6 million over the same period. Long-term debt remained relatively stable at $47.9 million. Still, much of the balance-sheet growth is associated with insurance-related assets and liabilities rather than unrestricted corporate cash.

Retail investors should also note that Hippo’s liquidity ratios remain weak on a simple balance-sheet basis. Q2 current assets of $595.4 million were below current liabilities of $1.03 billion, implying a current ratio of approximately 0.58. The company also reported $1.20 billion of accumulated retained-earnings losses, although retained losses improved from $1.32 billion in Q2 2025. The financial data includes several restated historical periods, so comparisons with earlier quarters should be treated cautiously.

  • Revenue growth: Quarterly revenue has more than quadrupled from $28.7 million in Q2 2022 to $144.7 million in Q2 2026.
  • Operating turnaround: Gross profit and operating income have moved decisively into positive territory, with Q2 2026 operating income of $11.0 million.
  • Improving earnings: Net income attributable to common shareholders reached $10.1 million in Q2 2026, producing diluted EPS of $0.38.
  • Stronger operating cash flow: Q2 2026 operating cash flow of $43.1 million was substantially higher than the $8.5 million generated in Q1 2026.
  • Stable traditional debt: Long-term debt remained at $47.9 million from Q1 to Q2 2026, limiting the impact of conventional borrowing costs.
  • Investment portfolio activity: Hippo continues to purchase and sell large amounts of investments, which supports liquidity management but can make quarterly cash movements difficult to interpret.
  • Weak current ratio: Current liabilities exceeded current assets in Q2 2026, with $1.03 billion of current liabilities versus $595.4 million of current assets.
  • Cash declined in the latest quarter: Despite positive operating cash flow, net cash fell by $76.3 million because of investment purchases and other investing activity.
  • Large accumulated losses: Retained earnings remained negative at approximately $1.20 billion, reflecting the company’s substantial historical losses.
  • Share-count dilution: Weighted-average basic shares increased from 23.2 million in Q1 2023 to 26.2 million in Q2 2026, which can reduce the benefit of earnings growth for each individual share.
11/17/26 03:35 PM ETAI Generated. May Contain Errors.

Hippo Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Hippo's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Hippo's net income appears to be on an upward trend, with a most recent value of $62.60 million in 2025, compared with -$141.40 million in 2020. The previous period was -$28.60 million in 2024. Find out what analysts predict for Hippo in the coming months.

Hippo's total operating income in 2025 was -$31.70 million, based on the following breakdown:
  • Total Gross Profit: $107.40 million
  • Total Operating Expenses: $139.10 million

Over the last 5 years, Hippo's total revenue changed from $51.60 million in 2020 to $468.60 million in 2025, a change of 808.1%.

In the past 14 quarters, Hippo's cash and equivalents has ranged from $140.90 million in Q1 2025 to $311.80 million in Q3 2026, and is currently $311.80 million as of their latest financial filing in Q3 2026.

Hippo had total debt of $47.90 million at the end of 2025, compared with none in 2024, and a 82.5% decrease since 2020.

Over the last 5 years, Hippo's book value per share changed from -2.30 in 2020 to 17.21 in 2025.



Financial statements for NYSE:HIPO last updated on 10/29/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners